Katherine A. Vernon

612 total citations
5 papers, 190 citations indexed

About

Katherine A. Vernon is a scholar working on Nephrology, Immunology and Hematology. According to data from OpenAlex, Katherine A. Vernon has authored 5 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 5 papers in Immunology and 2 papers in Hematology. Recurrent topics in Katherine A. Vernon's work include Renal Diseases and Glomerulopathies (5 papers), Complement system in diseases (5 papers) and Platelet Disorders and Treatments (2 papers). Katherine A. Vernon is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Complement system in diseases (5 papers) and Platelet Disorders and Treatments (2 papers). Katherine A. Vernon collaborates with scholars based in United Kingdom, United States and France. Katherine A. Vernon's co-authors include Matthew C. Pickering, Elena Goicoechea de Jorge, Kirsten L. Rose, Mitali Patel, Michelle P. Winn, Peter Lavin, Marcel A. de Leeuw, Talat H. Malik, Peter J. Conlon and Véronique Frémeaux‐Bacchi and has published in prestigious journals such as Journal of the American Society of Nephrology, American Journal of Kidney Diseases and Molecular Immunology.

In The Last Decade

Katherine A. Vernon

5 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine A. Vernon United Kingdom	4	162	147	73	29	25	5	190
Spero R. Cataland United States	3	226 1.4×	170 1.2×	57 0.8×	5 0.2×	34 1.4×	4	244
Emilia Arjona Spain	8	175 1.1×	117 0.8×	86 1.2×	1 0.0×	21 0.8×	15	197
Holger Schirutschke Germany	6	81 0.5×	35 0.2×	75 1.0×	7 0.2×	6 0.2×	11	148
Silvia Pontiggia Italy	8	191 1.2×	98 0.7×	112 1.5×	3 0.1×	105 4.2×	16	211
Agathe Debliquis France	6	39 0.2×	14 0.1×	23 0.3×	5 0.2×	35 1.4×	17	92
DM Rowczenio United Kingdom	5	73 0.5×	64 0.4×	31 0.4×	9 0.3×	7 0.3×	16	180
Desmond Creagh United Kingdom	2	150 0.9×	70 0.5×	113 1.5×	1 0.0×	94 3.8×	2	214
Hakim Tayebi France	7	130 0.8×	8 0.1×	132 1.8×	5 0.2×	8 0.3×	8	194
Avraam Elia Cyprus	7	14 0.1×	133 0.9×	59 0.8×	13 0.4×	45 1.8×	10	235

Countries citing papers authored by Katherine A. Vernon

Since Specialization

Citations

This map shows the geographic impact of Katherine A. Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine A. Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine A. Vernon more than expected).

Fields of papers citing papers by Katherine A. Vernon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine A. Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine A. Vernon. The network helps show where Katherine A. Vernon may publish in the future.

Co-authorship network of co-authors of Katherine A. Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine A. Vernon. A scholar is included among the top collaborators of Katherine A. Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine A. Vernon. Katherine A. Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Jilma, Bernd, Katherine A. Vernon, Stefan Wawersik, et al.. (2024). ADX-097, a Tissue-Targeted Complement Inhibitor for the Treatment of Kidney Diseases: Phase 1 Results in Healthy Participants and Model-Informed Phase 2 Dose Selection. Journal of the American Society of Nephrology. 35(10S). 2 indexed citations

2.

Vernon, Katherine A., Elena Goicoechea de Jorge, Véronique Frémeaux‐Bacchi, et al.. (2012). Acute Presentation and Persistent Glomerulonephritis Following Streptococcal Infection in a Patient With Heterozygous Complement Factor H–Related Protein 5 Deficiency. American Journal of Kidney Diseases. 60(1). 121–125. 75 indexed citations

3.

Malik, Talat H., Peter Lavin, Elena Goicoechea de Jorge, et al.. (2012). A Hybrid CFHR3-1 Gene Causes Familial C3 Glomerulopathy. Journal of the American Society of Nephrology. 23(7). 1155–1160. 99 indexed citations

4.

Vernon, Katherine A., Matthew C. Pickering, & Terence Cook. (2011). Experimental Models of Membranoproliferative Glomerulonephritis, Including Dense Deposit Disease. Contributions to nephrology. 169. 198–210. 10 indexed citations

5.

Vernon, Katherine A., Daniel P. Gale, Elena Goicoechea de Jorge, et al.. (2010). Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant. Molecular Immunology. 47(13). 2202–2202. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact